---
title: "Relmada Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/82e8ea9d-251f-56bd-aaa7-8bbc10eda735
json: https://whiteintel.dev/api/public/dossier/82e8ea9d-251f-56bd-aaa7-8bbc10eda735
identifier: lei:549300217EASRZ9JSF81
jurisdiction: US-NV
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Relmada Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** US-NV  
**Identifier:** `lei:549300217EASRZ9JSF81`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/82e8ea9d-251f-56bd-aaa7-8bbc10eda735  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/82e8ea9d-251f-56bd-aaa7-8bbc10eda735  

## Registry profile

- **Status:** LAPSED  
- **Legal form:** `8WM4`  
- **Source:** GLEIF  

## Provenance

- GLEIF — https://search.gleif.org/#/record/549300217EASRZ9JSF81

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Relmada Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/82e8ea9d-251f-56bd-aaa7-8bbc10eda735 · Structured JSON: https://whiteintel.dev/api/public/dossier/82e8ea9d-251f-56bd-aaa7-8bbc10eda735._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._